HCM vs. BRK-B
HCM (HUTCHMED (China) Limited) and BRK-B (Berkshire Hathaway Inc.) are both stocks. HCM operates in Biotechnology (Healthcare), while BRK-B operates in Insurance - Diversified (Financial Services). Over the past 10 years, HCM returned -1.73%/yr vs 12.91%/yr for BRK-B. At a 0.15 correlation, their price movements are largely independent.
Performance
HCM vs. BRK-B - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, HCM achieves a -15.15% return, which is significantly lower than BRK-B's -5.43% return. Over the past 10 years, HCM has underperformed BRK-B with an annualized return of -1.73%, while BRK-B has yielded a comparatively higher 12.91% annualized return.
HCM
- 1D
- -1.82%
- 1M
- -14.45%
- YTD
- -15.15%
- 6M
- -20.69%
- 1Y
- -23.06%
- 3Y*
- -3.28%
- 5Y*
- -17.77%
- 10Y*
- -1.73%
BRK-B
- 1D
- 0.82%
- 1M
- 1.46%
- YTD
- -5.43%
- 6M
- -5.61%
- 1Y
- -4.51%
- 3Y*
- 13.00%
- 5Y*
- 10.20%
- 10Y*
- 12.91%
HCM vs. BRK-B - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
HCM HUTCHMED (China) Limited | -15.15% | -7.49% | -20.43% | 22.53% | -57.87% | 9.56% | 27.72% | 8.58% | -41.43% | 190.49% |
BRK-B Berkshire Hathaway Inc. | -5.43% | 10.89% | 27.09% | 15.46% | 3.31% | 28.95% | 2.37% | 10.93% | 3.01% | 21.62% |
Correlation
The correlation between HCM and BRK-B is 0.00, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.00 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.09 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.13 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.15 |
Correlation (All Time) Calculated using the full available price history since Mar 18, 2016 | 0.15 |
The correlation between HCM and BRK-B shifts across timeframes, from 0.00 (1 year) to 0.15 (all time), reflecting how their relationship changes across market environments.
Fundamentals
HCM:
$2.68
BRK-B:
$33.62
HCM:
4.23
BRK-B:
14.14
HCM:
0.01
BRK-B:
0.55
HCM:
3.28
BRK-B:
2.73
HCM:
$602.20M
BRK-B:
$375.39B
HCM:
$53.76M
BRK-B:
$94.36B
HCM:
-$7.49M
BRK-B:
$71.92B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
HCM vs. BRK-B — Risk / Return Rank
HCM
BRK-B
HCM vs. BRK-B - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for HUTCHMED (China) Limited (HCM) and Berkshire Hathaway Inc. (BRK-B). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| HCM | BRK-B | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.29 | ||
| Sortino ratioReturn per unit of downside risk | -0.38 | ||
| Omega ratioGain probability vs. loss probability | 0.92 | 0.96 | -0.04 |
| Calmar ratioReturn relative to maximum drawdown | -0.56 | -0.48 | -0.08 |
| Martin ratioReturn relative to average drawdown | -1.02 | -1.02 | 0.00 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| HCM | BRK-B | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.61 | -0.32 | -0.29 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.27 | 0.60 | -0.87 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.03 | 0.67 | -0.70 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.03 | 0.48 | -0.51 |
Drawdowns
HCM vs. BRK-B - Drawdown Comparison
The maximum HCM drawdown since its inception was -82.18%, which is greater than BRK-B's maximum drawdown of -53.86%. Use the drawdown chart below to compare losses from any high point for HCM and BRK-B.
Loading charts...
Drawdown Indicators
| HCM | BRK-B | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -82.18% | -53.86% | -28.32% |
Max Drawdown (1Y)Largest decline over 1 year | -41.54% | -9.42% | -32.12% |
Max Drawdown (3Y)Largest decline over 3 years | -48.44% | -14.95% | -33.49% |
Max Drawdown (5Y)Largest decline over 5 years | -82.18% | -26.58% | -55.60% |
Max Drawdown (10Y)Largest decline over 10 years | -82.18% | -29.57% | -52.61% |
Current DrawdownCurrent decline from peak | -73.66% | -11.94% | -61.72% |
Average DrawdownAverage peak-to-trough decline | -40.15% | -11.07% | -29.08% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 22.63% | 4.57% | +18.06% |
Volatility
HCM vs. BRK-B - Volatility Comparison
HUTCHMED (China) Limited (HCM) has a higher volatility of 7.70% compared to Berkshire Hathaway Inc. (BRK-B) at 3.75%. This indicates that HCM's price experiences larger fluctuations and is considered to be riskier than BRK-B based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| HCM | BRK-B | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.70% | 3.75% | +3.95% |
Volatility (6M)Calculated over the trailing 6-month period | 22.37% | 10.68% | +11.69% |
Volatility (1Y)Calculated over the trailing 1-year period | 38.76% | 14.33% | +24.43% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 66.10% | 17.11% | +48.99% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 59.36% | 19.43% | +39.93% |
Dividends
HCM vs. BRK-B - Dividend Comparison
Neither HCM nor BRK-B has paid dividends to shareholders.
Financials
HCM vs. BRK-B - Financials Comparison
This section allows you to compare key financial metrics between HUTCHMED (China) Limited and Berkshire Hathaway Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
HCM and BRK-B have a correlation of 0.00, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
HCM has higher volatility (7.70%) compared to BRK-B (3.75%). In terms of maximum drawdown, HCM dropped -82.18% vs BRK-B's -53.86%.
BRK-B currently has the higher Sharpe Ratio (-0.32 vs -0.61), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for HCM and BRK-B
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer